Site Management Organization

Service Description

Our Vision To transform investigator-owned facilities into centers of excellence for clinical research by: 1. Providing Infrastructure Support: Equipping sites with the tools and technology required to meet international standards. 2. Investigator Empowerment: Offering comprehensive training, operational guidance, and end-to-end support for trial execution. 3. Promoting Patient Access: Enabling underserved communities to participate in clinical research. Clinovate’s Approach 1. Site Development • Assessment of site readiness, followed by customized infrastructure and operational support. • Implementation of SOPs that align with GCP and regulatory guidelines. 2. Investigator Partnerships • Collaboration with investigators to co-develop trial sites, creating a sustainable research ecosystem. • Ongoing training in protocol adherence, data management, and patient engagement. 3. Seamless Operations • Support for patient recruitment through community outreach and awareness programs. • Centralized coordination for regulatory submissions, ethics committee approvals, and monitoring. 4. Technology Integration • Digital tools for real-time trial monitoring and data collection. • EDC system integration for improved accuracy and compliance. Why Clinovate? • Focused Expertise: Dedicated to investigator-owned sites, ensuring tailored support. • Accelerated Timelines: Streamlined operations for faster trial initiation and completion. • Cost Efficiency: Leveraging existing healthcare infrastructure to minimize costs. • Patient-Centricity: Bringing trials to trusted local settings, enhancing patient trust and participation. Case Study Vision For example, at a 50-bed nursing home, Clinovate could: • Transform the facility into a trial-ready site. • Recruit and train local staff to meet trial protocol requirements. • Achieve a 90% patient retention rate by offering trials in a familiar and trusted environment. Conclusion At Clinovate, we are reimagining site management by empowering investigator- owned facilities to lead the way in clinical research. Together, we can expand access to cutting-edge treatments and advance global healthcare innovation.